AGENDA
| Activity | Time |
| Registration Placing of the poster on the board Setting up the exhibitors’ table |
09:00 – 14:00 |
| SPEAKER | TITLE | TIME |
| Prof. Paolo Martelli (University Rector) Francesca Buttini (University of Parma) |
Conference opening: Welcome and Introduction | 14:00-14:20 |
|
NEW PARADIGMS IN LUNG DELIVERY
|
||
|
Chairs: TBD |
||
| Melanie Ott (Gladstone Institutes) |
In the Air Around Us: Understanding and Outpacing Viral Threats | 14:20 – 15:00 |
| Janice Glines (Vertex) |
Global Regulatory CMC strategies for orally inhaled therapeutics | 15:00 – 15:25 |
| Michael Goller (TranspireBio) |
Expanding Inhalation Therapies beyond Asthma and COPD | 15:25 – 15:50 |
|
COFFEE BREAK + POSTER SESSION |
||
|
Chairs: TBD |
||
| Vivek Lal (Alveolus Bio) |
Nanomedicines and microparticles for the treatment of pulmonary infections | 16:30 – 16:55 |
| TBD | 16:55 – 17:20 | |
| Bespak (Sponsor) |
17:20 – 17:30 | |
| Selected from Abstract | 17:30 – 17:45 | |
|
WELCOME RECEPTION (17:45 – 19:15)
|
||
|
AEROSOLS OF LUNG INFECTION
|
||
|
Chairs: TBD |
||
| Mercedes Gonzalez-Juarrero (Colorado University) |
Preclinical development of aerosol therapy for M. abcessus pulmonary disease | 09:00 – 09:25 |
| Sara Maloney (RTI International) |
Probiotic-bacteriophage aerosols for treating bacterial lung infections | 09:25 – 09:50 |
| Philip Kwok (University of Sydney) |
Expanding Inhalation Therapies beyond Asthma and COPD | 09:50 – 10:15 |
| Selected from abstract | 10:15 – 10:30 | |
|
COFFEE BREAK + POSTER SESSION |
||
|
Chair: Jayne Hastedt |
||
| Philip Kuehl (Aptar Pharma) |
Preclinical Tools for Advancing Pulmonary and Nasal Drug Products | 11:10 – 11:35 |
| ROUND TABLE | 1000 Years of Experience, 16 Years of Progress: What Still Remains? | 11:35 – 12:40 |
|
LIGHT LUNCH + POSTER SESSION (17:45 – 19:15) |
||
|
RNA DELIVERY ACCROS MUCUS
|
||
|
Chairs: TBD |
||
| Keynote Speaker Justin Hanes (Johns Hopkins University) |
The Airway Mucus Barrier and How to Overcome it | 14:00 – 14:40 |
| Shrirang Karve (Sanofi) |
Holistic Platform for Efficient Pulmonary mRNA Delivery: Integrating Novel Ionizable Lipids & Device Engineering | 14:40 – 15:05 |
| Koen Raemdonck (Ghent University) |
Inhalable RNA formulations for pulmonary diseases | 15:05 – 15:30 |
|
COFFEE BREAK + POSTER SESSION |
||
|
PRECLINICAL MODELS AND DEVICE INNOVATION
|
||
|
Chairs: TBD |
||
| H&T Presspart (Sponsor) |
16:10 – 16:20 | |
| Aptar Pharma (Sponsor) |
16:20 – 16:30 | |
| Murat Ali (Phillips Medisize) |
Enabling Therapies Today and Tomorrow: Demonstrating the Versatility of Blister-Based Dry Powder Inhalers for Current and Future Drug Delivery | 16:30 – 16:55 |
|
EMERGING PERSPECTIVES IN RESPIRATORY DISEASE
|
||
|
Chairs: TBD |
||
| Keynote Speaker David Edwards (SC Therapeutics) |
Airway inflammation and hypertension | 09:00 – 09:40 |
| Andrea Casazza (Chiesi Farmaceutici) |
The Therapeutic Pipeline in Respiratory Diseases | 09:40 – 10:05 |
| Stefano Aliberti (Humanitas Research Hospital) |
||
pMDIs AT 70: PAST, PRESENT AND FUTURE |
||
|
Chairs: TBD |
||
| Orbia (Sponsor) |
10:30 – 10:40 | |
| Solstice (Sponsor) |
10:40 – 10:50 | |
|
COFFEE BREAK + POSTER SESSION |
||
|
Chairs: TBD |
||
| David Lewis (Oz-Uk Ltd) |
From First Principles to Measured Performance: pMDIs in the Low-GWP Era | 11:30 – 11:45 |
| TBD | 11:45 – 12:00 | |
| TBD | 12:00 – 12:15 | |
| TBD | 12:15 – 12:30 | |
| TBD | 12:30 – 13:00 | |
|
LIGHT LUNCH + POSTER SESSION |
||
|
NASAL DELIVERY OF BIOLOGICS AND RNA
|
||
|
Chairs: TBD |
||
| Nathalie Heuzé-Vourc’h (National Institute of Biomedical Research) |
Exploring Intranasal Delivery of Anti-Infective Antibodies | 14:30 – 14:55 |
| Chantelle Ahlenstiel (Kirby Institute) |
Respiratory delivery of antiviral RNA therapeutics | 14:55 – 15:20 |
| Selected from Abstract | 15:20 – 15:35 | |
| Katharina Schindowski (Biberach University) |
Intranasal nose-to-brain delivery of a monoclonal antibody with a controlled release drug delivery system: proof-of-concept and pharmacokinetic studies in mini pigs | 15:35 – 16:00 |
|
COFFEE BREAK + POSTER SESSION |
||
|
ADVANCES IN SOFT MIST INHALATION
|
||
|
Chairs: TBD |
||
| Rémi Rosière (InhaTarget Therapeutics) |
Exploring Intranasal Delivery of Anti-Infective Antibodies | 16:30 – 16:55 |
| Selected from Abstract | 16:55 – 17:10 | |
| Francesca Buttini | CLOSING REMARKS | 17:10 – 17:15 |
|
GALA DINNER (FROM 20:00) |
||
CONFIRMED PLENARY SPEAKERS
David Edwards
SC Therapeutics, US
Justin Hanes
Johns Hopkins University, US
CONFIRMED INVITED SPEAKERS
Mercedes Gonzalez-Juarrero
Colorado State University, US
Nathalie Heuzé-Vourc’h
National Institute of Biomedical Research, France
Shrirang Karve
Sanofi, US
Philip Kuehl
Aptar Pharma, US
Philip Kwok
University of Sydney, Australia
Michael Goller
Transpire Bio, US
Vivek Lal
Alveolus Bio, US
David Lewis
Oz-UK Ltd, UK
Sara Maloney
RTI International, US
John Pritchard
Inspiring Strategies, UK
Koen Raemdonck
Ghent University, Belgium
Steve Stein
CGT Pharma Consulting, US
Rémi Rosière
InhaTarget Therapeutics, Belgium
Katharina Schindowski
Biberach University, Germany
